Documentdetail
ID kaart
oai:arXiv.org:2412.09376
Onderwerp
Computer Science - Machine Learnin...Auteur
Vlontzou, Maria Eleftheria Athanasiou, Maria Dalakleidi, Kalliopi Skampardoni, Ioanna Davatzikos, Christos Nikita, KonstantinaCategorie
Computer Science
Jaar
2024
vermelding datum
19-03-2025
Trefwoorden
alzheimer diagnosis disease interpretability machineBeschrijving
An interpretable machine learning (ML) framework is introduced to enhance the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) by ensuring robustness of the ML models' interpretations.
The dataset used comprises volumetric measurements from brain MRI and genetic data from healthy individuals and patients with MCI/AD, obtained through the Alzheimer's Disease Neuroimaging Initiative.
The existing class imbalance is addressed by an ensemble learning approach, while various attribution-based and counterfactual-based interpretability methods are leveraged towards producing diverse explanations related to the pathophysiology of MCI/AD.
A unification method combining SHAP with counterfactual explanations assesses the interpretability techniques' robustness.
The best performing model yielded 87.5% balanced accuracy and 90.8% F1-score.
The attribution-based interpretability methods highlighted significant volumetric and genetic features related to MCI/AD risk.
The unification method provided useful insights regarding those features' necessity and sufficiency, further showcasing their significance in MCI/AD diagnosis.
Vlontzou, Maria Eleftheria,Athanasiou, Maria,Dalakleidi, Kalliopi,Skampardoni, Ioanna,Davatzikos, Christos,Nikita, Konstantina, 2024, A comprehensive interpretable machine learning framework for Mild Cognitive Impairment and Alzheimer's disease diagnosis
Choice Between Partial Trajectories: Disentangling Goals from Beliefs
agents models aligned based bootstrapped learning reward function model return choice choices partial
Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review
aes medications bta incidence migraine drugs disorders
